Management Presentation: Biosimilar Pipeline and Margin Improvement Strategy
Attractive market fundamentals | Leadership and scale | Multiple growth drivers Margin improvement | Attractive financial outlook | Compelling sustainability story
Ⓒ Procurement optimization expected to contribute substantially
to operational improvements in the mid-term
Current scale
and complexity
>USD 4bn
of external spend
>13,600
suppliers
Fragmented and dependent
procurement organization
Multiple procurement initiatives for standalone Sandoz
Leverage
scale
Reduce
complexity
Improve
organization
•
•
•
•
•
Contract negotiation
Consolidate suppliers and leverage strategic partnerships
•
Drive API and direct material substitution
Optimize indirect services
•
Harmonize and simplify product portfolio
•
Exploit advanced data, analytics and digital tools
Improve internal demand management
Simplify internal business processes
Global Head Procurement appointed
Consolidate procurement team
Expedite exit of agreements with Novartis
21 Management Presentation
SANDOZView entire presentation